Secukinumab effects on disease burden, patient needs and benefits, and treatment satisfaction in patients with plaque psoriasis across European regions: patient perspective data from the PROSE study.
Neuza da SilvaRachel SommerC-E OrtmannP JagielloT BachhuberMatthias AugustinPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Differences in patients' needs and treatment satisfaction across Europe are likely a result of diverse medical systems, socio-economic status and infrastructural access. A patient-centred approach to treating psoriasis may fulfil patient needs and maximize treatment satisfaction. (NCT02752776).